These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?]. Margalit M, Elinav H, Goldin E, Ilan Y. Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825 [Abstract] [Full Text] [Related]
7. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy. Weismüller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP. J Hepatol; 2008 Jun; 48 Suppl 1():S38-57. PubMed ID: 18304683 [Abstract] [Full Text] [Related]
8. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies. van Milligen de Wit AW, van Deventer SJ, Tytgat GN. Am J Gastroenterol; 1995 Jun; 90(6):893-900. PubMed ID: 7771416 [Abstract] [Full Text] [Related]
11. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood. Maggiore G, Riva S, Sciveres M. Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308 [Abstract] [Full Text] [Related]
12. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. Jesudian AB, Jacobson IM. Rev Gastroenterol Disord; 2009 Mar; 9(2):E41-7. PubMed ID: 19668124 [Abstract] [Full Text] [Related]